O. Meany Medical Data & Project Management (O. Meany MD&PM)
This sponsor has funded 4 studies across 1 countries.
| EU PAS ID | Status | Title | Protocol uploaded | Results uploaded |
|---|---|---|---|---|
| 35350 | Planned | Longitudinal analysis of the efficacy and tolerability of dronabinol use in patients with severe ± chronic pain – a retrospective analysis of... | No | No |
| 45869 | Finalised | Retrosepctive Analysis of the efficacy and tolerability of pridinol in patients with muscle pain - an analysis of open-label real-world data provided... | No | No |
| 105823 | Finalised | Fremanezumab versus conventional preventive treatments as ≥2nd line prophylaxis of migraine – propensity score matched multiple cohort comparative... | No | No |
| 106076 | Finalised | Eptinezumab versus conventional preventive treatments as ≥2nd line prophylaxis of migraine – propensity score matched multiple cohort comparative... | No | No |
PAS by Risk Management Plan (RMP) requirement
O. Meany Medical Data & Project Management (O. Meany MD&PM)
The RMP for a medical product outlines strategies to identify, assess, and mitigate risks, including PAS for further evaluation.
Category 1 studies are imposed as condition of marketing authorisation.
Category 2 studies are imposed as specific obligation of marketing authorisation.
Category 3 studies are required under other circumstances.
PAS by study status
O. Meany Medical Data & Project Management (O. Meany MD&PM)
The study status is defined according to the timeline dates specified.
Planned studies have not collected any data yet.
Ongoing studies collect data and should publish protocols as soon as possible.
Finalised studies should publish results in the first two weeks after finalisation.
Countries
O. Meany Medical Data & Project Management (O. Meany MD&PM)
1 Study countries specified are the following:
- Germany